Identification and validation of transcriptome-wide association study-derived genes as potential druggable targets...

Area of Science:

• Genetics
• Molecular Biology
• Rheumatology

Background:

• Osteoarthritis (OA) is a prevalent degenerative joint disease with complex genetic and environmental causes.
• Current understanding of OA's genetic mechanisms is incomplete, limiting targeted therapies.

Purpose of the Study:

• To identify tissue-specific candidate genes for osteoarthritis (OA).
• To validate high-confidence druggable gene targets for OA.
• To gain insights into the genetic landscape and biological processes of OA.

Main Methods:

• A transcriptome-wide association study (TWAS) using the FUSION algorithm was performed for site-specific OA.
• Rigorous quality control, including joint/conditional analysis and colocalization, identified high-confidence genes.
• Co-expression network analysis, druggable target identification (DrugBank, SWISS-MODEL), and biochemical validation of MAPK3 and SMAD3 were conducted.

Main Results:

• TWAS identified 794 candidate OA genes; 14 were high-confidence, with seven identified as potential drug targets (GCAT, MAPK3, MST1R, PFKM, RAD9A, SMAD3, USAP8).
• Co-expression analysis highlighted a strong association between SMAD3 and MAPK3.
• In vitro, in vivo, and human histological studies confirmed enriched expression and high activity of MAPK3 and SMAD3 in OA.

Conclusions:

• This research identified novel tissue-specific candidate genes and validated druggable targets for OA.
• The findings provide new insights into OA's genetic basis and biological pathways.
• Further functional studies are recommended to validate these potential therapeutic targets.